Suscribirse

Association between asthma and rhinitis according to atopic sensitization in a population-based study - 24/08/11

Doi : 10.1016/j.jaci.2003.10.010 
Bénédicte Leynaert, PhD a, ⁎, Catherine Neukirch, MD a, Sabine Kony, PhD a, Armelle Guénégou, MSc a, Jean Bousquet, MD, PhD b, Michel Aubier, MD, PhD a, Françoise Neukirch, MD a

on behalf of the European Community Respiratory Health Survey

a Inserm Unité 408, Paris, France 
b Inserm Unité 454, Montpellier, France 

Reprint requests: Bénédicte Leynaert, Inserm Unité 408, Epidémiologie Faculté de Médecine X. Bichat, BP 416-75870, Paris Cedex 18, France

Abstract

Background

Although asthma and rhinitis often occur together, the reason for this common comorbidity is still a matter of debate.

Objective

We sought to assess whether the coexistence of asthma and rhinitis could be explained by common risk factors.

Methods

International cross-sectional study of representative samples of young adults, who completed a detailed questionnaire and underwent lung function tests, bronchoprovocation challenge, IgE measurements, and skin prick tests.

Results

In all countries, asthma and bronchial hyperreactivity were more frequent in subjects with rhinitis than in those without (odds ratio [OR], 6.63; 95% CI, 5.44-8.08; and OR, 3.02 95% CI, 2.66-3.43, respectively). Seventy-four percent to 81% of subjects with asthma reported rhinitis, depending on sensitization to specific allergens. Conversely, the risk of asthma increased from 2.0% in subjects without rhinitis to 6.7% in subjects with rhinitis only when exposed to pollen, 11.9% in subjects with rhinitis when exposed to animals, and 18.8% in subjects with rhinitis either when exposed to pollen or to animals. The association between rhinitis and asthma remained significant after adjustment for total IgE, parental history of asthma, and allergen sensitization (OR, 3.41; 95% CI, 2.75-4.2 suggesting that the coexistence of asthma and rhinitis is not solely due to atopic predisposition to these 2 diseases.

Conclusions

Although there were some variations in the association between asthma and rhinitis according to sensitization to individual allergens, the strong association between asthma and rhinitis was not fully explained by shared risk factors, including atopy. Our findings are consistent with the hypothesis that rhinitis might increase the risk of asthma.

El texto completo de este artículo está disponible en PDF.

Keywords : Epidemiology, rhinitis, asthma, pollen, allergens, hypersensitivity, bronchial hyperreactivity

Abbreviations : BHR, ECRHS, OR


Esquema


 The following grants helped to fund the local studies: Australia: Allen and Hanbury's, Australia. Belgium: Belgian Science Policy Office, National Fund for Scientific Research. France: Ministère de la Santé, Glaxo France, Institut Pneumologique d'Aquitaine, Contrat de Plan Etat-Région Languedoc-Roussillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre délégué de la santé, RNSP. Germany: GSF, and the Bundesminister für Forschung und Technologie, Bonn. Greece: The Greek Secretary General of Research and Technology, Fisons, Astra, and Boehringer-Ingelheim. India: Bombay Hospital Trust. Italy: Ministero dell'Univesitàe della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93. New Zealand: Asthma Foundation of New Zealand, Lotteries Grant Board, Health Research Council of New Zealand. Norway: Norwegian Research Council project no. 101422/310. Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa. Spain: Ministero Sanidad y Consumo FIS (grants #91/0016060/OOE-05E., #92/0319, #93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménenz, Consejeria de Sanidad Principado de Asturias. Sweden: The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy, The Swedish Society of Medicine, Astra, Glaxo-Wellcome, Boehringer-Ingelheim. Switzerland: Swiss National Science Foundation grant 4026-28099. United Kingdom: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority. United States: United States Department of Health, Education and Welfare Public Health Service Grant #2 S07 RR05521-28.
Special thanks to UCB-Pharma-France for their financial support for this analysis.


© 2004  American Academy of Allergy, Asthma and Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 113 - N° 1

P. 86-93 - janvier 2004 Regresar al número
Artículo precedente Artículo precedente
  • On the move?
| Artículo siguiente Artículo siguiente
  • Difficult asthma in children : An analysis of airway inflammation
  • Jacques de Blic, Isabelle Tillie-Leblond, André Bernard Tonnel, Francis Jaubert, Pierre Scheinmann, Philippe Gosset

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.